SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 199 filers reported holding SELECT MED HLDGS CORP in Q3 2018. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $282,000 | +12.8% | 11,337 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $250,000 | -6.4% | 11,337 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $267,000 | -63.9% | 11,337 | -75.7% | 0.01% | +250.0% |
| Q2 2019 | $739,000 | -0.3% | 46,568 | -11.5% | 0.00% | 0.0% |
| Q1 2019 | $741,000 | -16.2% | 52,621 | -8.6% | 0.00% | -33.3% |
| Q4 2018 | $884,000 | -13.4% | 57,567 | +3.8% | 0.00% | 0.0% |
| Q3 2018 | $1,021,000 | -4.6% | 55,465 | -5.9% | 0.00% | 0.0% |
| Q2 2018 | $1,070,000 | +11.6% | 58,931 | +6.0% | 0.00% | 0.0% |
| Q1 2018 | $959,000 | +45.5% | 55,613 | +49.0% | 0.00% | +50.0% |
| Q4 2017 | $659,000 | -1.1% | 37,325 | +7.5% | 0.00% | 0.0% |
| Q3 2017 | $666,000 | +25.0% | 34,710 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $533,000 | +15.1% | 34,710 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $463,000 | -51.8% | 34,710 | -52.1% | 0.00% | -66.7% |
| Q4 2016 | $960,000 | -1.8% | 72,430 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $978,000 | – | 72,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 13,100,000 | $156,021,000 | 15.53% |
| Antipodean Advisors LLC | 4,133,825 | $49,234,000 | 7.18% |
| Camber Capital Management LP | 4,500,000 | $53,595,000 | 3.46% |
| DREMAN VALUE MANAGEMENT, L L C | 830,862 | $9,896,000 | 3.00% |
| Smith, Graham & Co., Investment Advisors, LP | 658,847 | $7,847,000 | 1.11% |
| BROADVIEW ADVISORS LLC | 661,630 | $7,880,000 | 1.11% |
| Foyston, Gordon, & Payne Inc | 400,257 | $4,767,000 | 0.90% |
| SENZAR ASSET MANAGEMENT, LLC | 492,000 | $5,859,720,000 | 0.65% |
| Capital Impact Advisors, LLC | 68,735 | $819,000 | 0.39% |
| Sivik Global Healthcare LLC | 64,709 | $771,000 | 0.37% |